HCA Holdings Inc. buy UBS Group AG
Start price
23.02.26
/
50%
€452.70
Target price
23.02.27
€536.83
Performance (%)
-18.80%
Price
28.07.26
€367.60
Summary
This prediction is currently active. The prediction for HCA Holdings Inc. disappoints with a performance of -18.80%. This prediction currently runs until 23.02.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| HCA Holdings Inc. | 5.576% | 5.576% |
| iShares Core DAX® | 2.992% | 3.220% |
| iShares Nasdaq 100 | -1.584% | -3.172% |
| iShares Nikkei 225® | -2.254% | -9.924% |
| iShares S&P 500 | -0.009% | 1.641% |
Comments by UBS_Group_AG for this prediction
In the thread HCA Holdings Inc. diskutieren
HCA Healthcare (NYSE:HCA) had its "buy" rating reaffirmed by analysts at UBS Group AG. They now have a $635.00 price target on the stock.
Ratings data for HCA provided by MarketBeat
Stopped prediction by UBS_Group_AG for HCA Holdings Inc.
HCA Holdings Inc.
Start price
Target price
Perf. (%)
€337.30
14.08.24
14.08.24
€396.96
14.08.25
14.08.25
0.33%
15.08.25
15.08.25
